Scholars Central

Conference abstractPublished 28 Sep 2015

The role of IL-17A in postmenopausal inflammatory events, such as in osteoporosis

Authors: Ildikó Molnár, Ilona Bohaty, Éva Somogyiné-Vári

Immunoendocrinology and Osteoporosis Centre, Hungary; National Blood Transfusion Service, Hungary

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Postmenopausal women demonstrate increased susceptibility to chronic inflammatory events. Estrogen deficiency increases the production of inflammatory cytokines such as IL-1, IL-6 and tumor necrosis factor-Ã?± (TNFÃ?±), as well as activates the IL- 17 receptor signaling pathway. IL-17 (also known as IL-17A) is a new candidate in the chronic inflammatory diseases, produced by T helper 17 (Th17) lymphocytes and effects on neutrophil recruitment and granulopoesis. We studied the relationship between IL-17A serum levels and estrogen deficiency, as well as IL-17A-mediated osteoporosis in postmenopausal women. Seventy-two post-menopausal and 22 pre-menopausal women formed the patient groups. Estradiol, osteoprotegerin (OPG), soluble receptor activator of NF-Ã?ºB (sRANK) ligand, IL-17A were measured with enzyme-linked immunoassy (ELISA) and dual-energy X-ray absorptiometry (DXA) was carried out. High prevalence of elevated IL-17A serum levels were demonstrated in postmeno pausal women compared to premenopausal ones (3.5Ã?±0.56 vs 2.88Ã?±0.08 ng/ml, P<0.0001). IL-17A levels showed age-related dependency and a remarkable association with the postmenopausal period (P<0.05). Osteoporotic women demonstrated higher IL-17A, OPG and sRANK ligand serum levels than those who had osteopenia (3.65Ã?±0.61 vs. 3.31Ã?±0.43 ng/ml for IL- 17A, P<0.007; 2.88Ã?±0.84 vs. 2.49Ã?±0.61 ng/mk for sRANK ligand, P<0.027; 1.43Ã?±0.07 vs. 1.39Ã?±0.07 ng/ml for OPG, P<0.038). IL-17A levels inversely correlated with total lumbar bone mineral densities (BMDs) (PÃ?0.0008, r=-0.279) and positively with sRANK ligand levels (P<0.0001, r=0.387). The results demonstrated a high prevalence of increased IL-17A serum levels in postmenopausal estrogen deficiency highlighting its role in chronic infflammatory events such as in bone loss and age-related susceptibility to chronic inflammatory diseases.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical and Cellular Immunology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Cellular Immunology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Ildikó Molnár”
  • BylineArticles whose byline prints “Ilona Bohaty”
  • BylineArticles whose byline prints “Éva Somogyiné-Vári”